BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25680864)

  • 1. Prognostic significance of systemic neutrophil and leukocyte alterations in surgically treated endometrial cancer patients: a monoinstitutional study.
    Takahashi R; Mabuchi S; Kawano M; Sasano T; Matsumoto Y; Kuroda H; Hisamatsu T; Kozasa K; Sawada K; Hamasaki T; Kimura T
    Gynecol Oncol; 2015 Apr; 137(1):112-8. PubMed ID: 25680864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Significance of Pretreatment Thrombocytosis and Its Association With Neutrophilia in Patients With Surgically Treated Endometrial Cancer.
    Takahashi R; Mabuchi S; Kuroda H; Kozasa K; Yokoi E; Matsumoto Y; Kimura T
    Int J Gynecol Cancer; 2017 Sep; 27(7):1399-1407. PubMed ID: 28604454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of pre-operative neutrophil/lymphocyte ratio, monocyte count, mean platelet volume, and platelet/lymphocyte ratio in endometrial cancer.
    Temur I; Kucukgoz Gulec U; Paydas S; Guzel AB; Sucu M; Vardar MA
    Eur J Obstet Gynecol Reprod Biol; 2018 Jul; 226():25-29. PubMed ID: 29804024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
    Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
    J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
    Toh E; Wilson J; Sebag-Montefiore D; Botterill I
    Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival.
    Cummings M; Merone L; Keeble C; Burland L; Grzelinski M; Sutton K; Begum N; Thacoor A; Green B; Sarveswaran J; Hutson R; Orsi NM
    Br J Cancer; 2015 Jul; 113(2):311-20. PubMed ID: 26079303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer.
    Mell LK; Meyer JJ; Tretiakova M; Khramtsov A; Gong C; Yamada SD; Montag AG; Mundt AJ
    Clin Cancer Res; 2004 Aug; 10(16):5546-53. PubMed ID: 15328195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma.
    Vance S; Yechieli R; Cogan C; Hanna R; Munkarah A; Elshaikh MA
    Gynecol Oncol; 2012 Jul; 126(1):16-9. PubMed ID: 22507535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancer.
    McNamara MG; Templeton AJ; Maganti M; Walter T; Horgan AM; McKeever L; Min T; Amir E; Knox JJ
    Eur J Cancer; 2014 Jun; 50(9):1581-9. PubMed ID: 24630393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
    Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
    Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of clinical utility between neutrophil count and neutrophil-lymphocyte ratio in patients with ovarian cancer: a single institutional experience and a literature review.
    Komura N; Mabuchi S; Yokoi E; Kozasa K; Kuroda H; Sasano T; Matsumoto Y; Kimura T
    Int J Clin Oncol; 2018 Feb; 23(1):104-113. PubMed ID: 28951992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective study of the prognostic significance of neutrophil-to-lymphocyte ratio for postsurgical outcomes of patients with endometrial carcinoma.
    Ding L; Ding Y; Mao XH; Zhao JF; Zhou HJ
    Int J Gynaecol Obstet; 2017 Sep; 138(3):311-319. PubMed ID: 28599056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-treatment neutrophil to lymphocyte ratio is a predictor of prognosis in endometrial cancer.
    Haruma T; Nakamura K; Nishida T; Ogawa C; Kusumoto T; Seki N; Hiramatsu Y
    Anticancer Res; 2015 Jan; 35(1):337-43. PubMed ID: 25550569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preoperative platelet count as index of the grading in endometrial carcinoma].
    Giannella L; Menozzi G; Di Monte I; Venturini P; De Pace V; Boselli F; Ternelli G; Jasonni VM
    Minerva Ginecol; 2008 Aug; 60(4):273-9. PubMed ID: 18560341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of preoperative plasma fibrinogen in endometrial cancer.
    Ghezzi F; Cromi A; Siesto G; Giudici S; Serati M; Formenti G; Franchi M
    Gynecol Oncol; 2010 Nov; 119(2):309-13. PubMed ID: 20688365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of monocyte counts on tumor characteristics and survival outcome of women with endometrial cancer.
    Matsuo K; Hom MS; Moeini A; Machida H; Takeshima N; Roman LD; Sood AK
    Gynecol Oncol; 2015 Aug; 138(2):332-8. PubMed ID: 26013698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
    Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
    Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas.
    Njølstad TS; Engerud H; Werner HM; Salvesen HB; Trovik J
    Gynecol Oncol; 2013 Nov; 131(2):410-5. PubMed ID: 24004646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.